| # | Drug | Count |
|---|---|---|
| 0 | RIBOCICLIB | 4 |
| 1 | CALCIUM | 3 |
| 2 | LETROZOLE | 3 |
| 3 | BEVACIZUMAB | 2 |
| 4 | CAPECITABINE | 2 |
| 5 | CELECOXIB | 2 |
| 6 | ESOMEPRAZOLE | 2 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 2 |
| 8 | HYDROXYCHLOROQUINE | 2 |
| 9 | LACOSAMIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LONCASTUXIMAB TESIRINE | 1 | 0.0024 |
| 1 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 1 | 0.0013 |
| 2 | ZALEPLON | 1 | 0.0006 |
| 3 | RIBOCICLIB | 4 | 0.0001 |
| 4 | DASPONE | 1 | 0.0001 |
| 5 | DAPSONE GEL, 5% | 1 | 0.0001 |
| 6 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 7 | POLATUZUMAB VEDOTIN | 1 | 0.0001 |
| 8 | DAPSONE | 1 | 0.0001 |
| 9 | GEMFIBROZIL | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 4 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 2 | Proton Pump Inhibitor [EPC] | 4 |
| 3 | Aromatase Inhibitor [EPC] | 3 |
| 4 | Calcium [EPC] | 3 |
| 5 | Corticosteroid [EPC] | 3 |
| 6 | Thalidomide Analog [EPC] | 3 |
| 7 | Anti-epileptic Agent [EPC] | 2 |
| 8 | Kinase Inhibitor [EPC] | 2 |
| 9 | Mood Stabilizer [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 2 | Sulfone [EPC] | 1 | 0.0001 |
| 3 | Progesterone [EPC] | 1 | 0.0000 |
| 4 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Aromatase Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 7 | Calcium [EPC] | 3 | 0.0000 |
| 8 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 9 | Nicotinic Acid [EPC] | 1 | 0.0000 |